Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 38 checked references that resolve
resolves10.1186/s12981-016-0111-1Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question
resolves10.1086/597262Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa
resolves10.1097/QAI.0b013e3182a39979Immunodeficiency at the Start of Combination Antiretroviral Therapy in Low-, Middle-, and High-Income Countries
resolves10.1093/cid/ciu1137Trends in CD4 Count at Presentation to Care and Treatment Initiation in Sub-Saharan Africa, 2002–2013: A Meta-analysis
resolves10.1001/jama.286.20.2568Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy
resolves10.1371/journal.pmed.1001418Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
resolves10.1371/journal.pone.0155256POC CD4 Testing Improves Linkage to HIV Care and Timeliness of ART Initiation in a Public Health Approach: A Systematic Review and Meta-Analysis
resolves10.1172/JCI115494Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction.
resolves10.1086/510073HIV Viral Load Monitoring in Resource‐Limited Regions: Optional or Necessary?
resolves10.1016/S1473-3099(13)70073-2Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis
resolves10.1136/bmj.d6884CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study
resolves10.1093/cid/ciw117Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies
resolves10.1097/QAI.0b013e31824276e9Prognostic Value of Virological and Immunological Responses After 6 Months of Antiretroviral Treatment in Adults With HIV-1 Infection in Sub-Saharan Africa
resolves10.7448/IAS.18.1.20061CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta‐analysis
resolves10.1371/journal.pmed.1002088Availability and Use of HIV Monitoring and Early Infant Diagnosis Technologies in WHO Member States in 2011–2013: Analysis of Annual Surveys at the Facility Level
resolves10.1097/QAI.0000000000001112Mortality in the First 3 Months on Antiretroviral Therapy Among HIV-Positive Adults in Low- and Middle-income Countries: A Meta-analysis
resolves10.1111/tmi.12746Stable patients and patients with advanced disease: consensus definitions to support sustained scale up of antiretroviral therapy
resolves10.1016/S0140-6736(15)60164-7Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial
resolves10.1097/QAD.0000000000000520Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda
resolves10.1093/cid/ciu288Advanced HIV Disease at Antiretroviral Therapy (ART) Initiation Despite Implementation of Expanded ART Eligibility Guidelines During 2007-2012 in Khayelitsha, South Africa
resolves10.1093/cid/ciu1138<i>Editorial Commentary</i>: Immunodeficiency at Start of Antiretroviral Therapy: The Persistent Problem of Late Presentation to Care
resolves10.1097/MD.0000000000002269HIV-Related Medical Admissions to a South African District Hospital Remain Frequent Despite Effective Antiretroviral Therapy Scale-Up
resolves10.1097/QAD.0000000000001005CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy
resolves10.1111/hiv.12389Reference curves for <scp>CD</scp>4 T‐cell count response to combination antiretroviral therapy in <scp>HIV</scp>‐1‐infected treatment‐naïve patients
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.